NEW YORK, April 18, 2017 -- Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Whitney Wolfe will join the firm as Managing Director to expand Equity Healthcare sales coverage in a new specialist role. Ms. Wolfe will join Guggenheim in May.
Ms. Wolfe joins Guggenheim from JMP Securities, where she was a Managing Director in Healthcare Equity Sales. Before working at JMP, she was at Bank of America Merrill Lynch, where she spent 15 years, most recently as an Equity Healthcare Specialist & Global Healthcare Coordinator.
“We are looking forward to Whitney joining our equity sales team,” said Jeff Cohen, Head of Equity Distribution. “Her extensive company and client coverage will bring an important new dimension to our sales function and will augment the success of our Healthcare research product.”
Ms. Wolfe received her B.A., Magna Cum Laude, from the University of Pennsylvania. She will be based in Guggenheim’s New York office.
About Guggenheim Partners
Guggenheim Partners is a global investment and advisory firm with more than $260 billion1 in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With more than 2,300 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.
1 Assets under management are as of 12.31.2016 and include consulting services for clients whose assets are valued at approximately $63bn.
Media Contacts Ellen Cunningham Guggenheim Partners 212.518.9578 [email protected]


Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Washington Post Publisher Will Lewis Steps Down After Layoffs
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



